To prevent tumor reproduction and metastasis, a method to modify the membranes of cancer cells was designed to suppress their vitality. A phosphatidyl choline reversed choline phosphate lipid (CP-Lip) was synthesized and modified with a PD-L1 antibody (CP-αPDL). Drug-loaded nanoparticles of CP-Lip/CP-αPDL (Dox@tCP-Lipos) could be selectively attached to melanoma cells, thus causing CP-Lip to be inserted and to interact strongly with the cell membrane, which largely reduced the fluidity and functionality of the membrane. As a result, the metabolism, reproduction, and migration of melanoma cells were proved to be weakened by CP-Lip and the tumor was 100% suppressed after treatment with Dox@tCP-Lipos.
Choline phosphate lipid insertion and rigidification of cell membranes for targeted cancer chemo-immunotherapy.
Shengran Li,Weikang Mei,Xiaozhen Wang,Sangni Jiang,Xinxin Yan,Sanrong Liu,Xifei Yu
Published 2021 in Chemical Communications
ABSTRACT
PUBLICATION RECORD
- Publication year
2021
- Venue
Chemical Communications
- Publication date
2021-01-12
- Fields of study
Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-28 of 28 references · Page 1 of 1
CITED BY
Showing 1-21 of 21 citing papers · Page 1 of 1